MedTrace Logo

3T MR Angiography of the Hepatic Vasculature

NCT02299934 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-05-07

Study results available
· View outcomes & findings →

Summary

This study plans to learn more about the two Magnetic Resonance Angiography (MRA) techniques.

Conditions

  • Liver Blood Supply

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

MRI sequences for visualisation of the blood supply of liver without contrast agent.

DIAGNOSTIC_TEST

Compurtized Tomgraphy (CT)

CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Samuel Chang · University of Colorado, Denver

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-09-30
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299934 on ClinicalTrials.gov